Results 261 to 270 of about 2,675,009 (295)

Asthma self-knowledge patient-reported outcome measures for the paediatric population with asthma: a systematic review protocol. [PDF]

BMJ Open
Gonçalves AS, Simões PA, Gama JMR, Jácome C, Maricoto T.   +4 more
europepmc   +1 more source

Characterization of WAC interactions with R2TP and TTT chaperone complexes linking glucose and glutamine availability to mTORC1 activity

FEBS Open Bio, EarlyView.
TTT and R2TP chaperone complexes are required for the assembly and activation of mTORC1. WAC directly interacts with components of TTT, R2TP, and mTORC1, and these interactions are affected by the availability of glucose and glutamine, correlating with changes in mTORC1 activity.
Sofía Cabezudo, Natalia Cuervo, Carmen García‐Martín, Andrés López‐Perrote, Clara Reglero, Adrián Maqueda‐Real, Ana González‐Corpas, Marina Serna, Diego Megías, Alejo Efeyan, Solip Park, Oscar Llorca   +11 more
wiley   +1 more source

Properties of Measurements of Patient-Reported Outcome Measures Physical Activity Assessment in Chronic Kidney Disease: A Systematic Review. [PDF]

Physiother Res Int
Stella TC, Santos IS, Alves da Silva G, Gomes CA, Malosá Sampaio LM.   +4 more
europepmc   +1 more source

Two‐way inhibition of PAX5 transcriptional activity by PAX5::CBFA2T3

FEBS Open Bio, EarlyView.
PAX5::CBFA2T3 (PAX5‐C) is a fusion protein of the B‐cell transcription factor, PAX5, and is found in B‐cell ALL. We propose a putative model of two‐way inhibition of PAX5 transcriptional activity by PAX5‐C. There are two ways of repression by PAX5‐C: DNA‐binding‐dependent way and HDAC‐dependent way, with either being sufficient for the repression. HDAC
Reina Ueno, Aki Terasaki, Yuiko Imai, Yuri Kimura, Yuna Kojima, Misa Irie, Koya Odaira, Mina Noura, Shuichi Okamoto, Takahiko Yasuda, Shinobu Tsuzuki, Hitoshi Kiyoi, Fumihiko Hayakawa   +12 more
wiley   +1 more source

A new validated Lymphoedema-specific Patient Reported Outcome Measure (LYMPROM) for adults with Lymphoedema. [PDF]

PLoS One
Thomas M, Gabe-Walters M, Humphreys I, Watkins A.   +3 more
europepmc   +1 more source

Patient Reported Outcome Measurements

Journal of Pharmaceutical Research, 2015
openaire   +2 more sources

Ro 31‐8220 suppresses bladder cancer progression via enhancing autophagy in vitro and in vivo

FEBS Open Bio, EarlyView.
The pan‐protein kinase C inhibitor Ro‐31‐8220 demonstrates potent anti‐bladder cancer effects both in vitro and in vivo by suppressing migration/invasion, inducing apoptosis and crucially activating autophagy, where blocking autophagy with chloroquine reduces its cell‐killing efficacy, suggesting its promise as a novel therapeutic candidate requiring ...
Shengjun Fu, Yan Tao, Shan Wu, Yuwen Gong, Youli Zhao, Shaomin Niu, Hui Cheng, You Mu, Na Xu, Ying Wang, Jianzhong Lu, Shanhui Liu, Lanlan Li   +12 more
wiley   +1 more source

Patient-reported outcome tools of acupuncture clinical trials in mainland China: a cross-sectional study. [PDF]

Front Neurol
Cao F, Dong Y, Li ZQ, Wang XF, Su CY, Lv JX, Shi ZY, Du MH, Zhang XY, Rong HG, Fei YT.   +10 more
europepmc   +1 more source

The benefits of capturing patient-reported outcome measures for treatment of obstructive sleep apnea with hypoglossal nerve stimulation. [PDF]

J Clin Sleep Med
Vanderveken OM.
europepmc   +1 more source

Using patient-reported outcome measures in clinical trials: perspectives for and against a modular approach. [PDF]

Med J Aust
Ng CA, Roydhouse J, Luckett T, Lourenco RA, Mulhern B.   +4 more
europepmc   +1 more source